These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 29664809)

  • 1. MicroRNA-19a/b-3p protect the heart from hypertension-induced pathological cardiac hypertrophy through PDE5A.
    Liu K; Hao Q; Wei J; Li GH; Wu Y; Zhao YF
    J Hypertens; 2018 Sep; 36(9):1847-1857. PubMed ID: 29664809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy.
    Tang CM; Liu FZ; Zhu JN; Fu YH; Lin QX; Deng CY; Hu ZQ; Yang H; Zheng XL; Cheng JD; Wu SL; Shan ZX
    Sci Rep; 2016 Oct; 6():36146. PubMed ID: 27796324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-92b-3p suppresses angiotensin II-induced cardiomyocyte hypertrophy via targeting HAND2.
    Yu XJ; Huang YQ; Shan ZX; Zhu JN; Hu ZQ; Huang L; Feng YQ; Geng QS
    Life Sci; 2019 Sep; 232():116635. PubMed ID: 31283925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA NEAT1 promotes cardiac hypertrophy through microRNA-19a-3p/SMYD2 axis.
    Sun XL; Lv JL; Dou L; Chen D; Zhu YC; Hu X
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1367-1377. PubMed ID: 32096186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-375-3p inhibitor suppresses angiotensin II-induced cardiomyocyte hypertrophy by promoting lactate dehydrogenase B expression.
    Feng H; Wu J; Chen P; Wang J; Deng Y; Zhu G; Xian J; Huang L; Ouyang W
    J Cell Physiol; 2019 Aug; 234(8):14198-14209. PubMed ID: 30618075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shenfu Injection attenuates rat myocardial hypertrophy by up-regulating miR-19a-3p expression.
    Mao ZJ; Zhang QL; Shang J; Gao T; Yuan WJ; Qin LP
    Sci Rep; 2018 Mar; 8(1):4660. PubMed ID: 29549288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-27b-3p down-regulates FGF1 and aggravates pathological cardiac remodelling.
    Li G; Shao Y; Guo HC; Zhi Y; Qiao B; Ma K; Du J; Lai YQ; Li Y
    Cardiovasc Res; 2022 Jul; 118(9):2139-2151. PubMed ID: 34358309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The miR-19a/b family positively regulates cardiomyocyte hypertrophy by targeting atrogin-1 and MuRF-1.
    Song DW; Ryu JY; Kim JO; Kwon EJ; Kim DH
    Biochem J; 2014 Jan; 457(1):151-62. PubMed ID: 24117217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of hsa-miR-19a-3p and hsa-miR-19b-3p modulation and phosphodiesterase type 5 expression in the vaginal epithelium of premenopausal women with genital arousal disorder.
    Caruso G; Falzone L; Palermo G; Ricci D; Mazza G; Libra M; Caruso S; Gattuso G
    J Sex Med; 2023 Jun; 20(7):935-944. PubMed ID: 37185899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-410-3p facilitates Angiotensin II-induced cardiac hypertrophy by targeting Smad7.
    Jia G; Liang C; Li W; Dai H
    Bioengineered; 2022 Jan; 13(1):119-127. PubMed ID: 34951337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of microRNA-22 derepressed PTEN to effectively protect rat cardiomyocytes from hypertrophy.
    Xu XD; Song XW; Li Q; Wang GK; Jing Q; Qin YW
    J Cell Physiol; 2012 Apr; 227(4):1391-8. PubMed ID: 21618527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thioredoxin 1 negatively regulates angiotensin II-induced cardiac hypertrophy through upregulation of miR-98/let-7.
    Yang Y; Ago T; Zhai P; Abdellatif M; Sadoshima J
    Circ Res; 2011 Feb; 108(3):305-13. PubMed ID: 21183740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-133a-3p attenuates cardiomyocyte hypertrophy through inhibiting pyroptosis activation by targeting IKKε.
    Zhu YF; Wang R; Chen W; Cao YD; Li LP; Chen X
    Acta Histochem; 2021 Jan; 123(1):151653. PubMed ID: 33246224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of MicroRNA-155 protects the heart from pathological cardiac hypertrophy.
    Seok HY; Chen J; Kataoka M; Huang ZP; Ding J; Yan J; Hu X; Wang DZ
    Circ Res; 2014 May; 114(10):1585-95. PubMed ID: 24657879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of miR-142-3p improves mitochondrial function in cardiac hypertrophy.
    Liu BL; Cheng M; Hu S; Wang S; Wang L; Tu X; Huang CX; Jiang H; Wu G
    Biomed Pharmacother; 2018 Dec; 108():1347-1356. PubMed ID: 30372837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NFATc3-dependent expression of miR-153-3p promotes mitochondrial fragmentation in cardiac hypertrophy by impairing mitofusin-1 expression.
    Wang T; Zhai M; Xu S; Ponnusamy M; Huang Y; Liu CY; Wang M; Shan C; Shan PP; Gao XQ; Wang K; Chen XZ; Liu J; Xie JY; Zhang DY; Zhou LY; Wang K
    Theranostics; 2020; 10(2):553-566. PubMed ID: 31903137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HSF1 deficiency accelerates the transition from pressure overload-induced cardiac hypertrophy to heart failure through endothelial miR-195a-3p-mediated impairment of cardiac angiogenesis.
    Wang S; Wu J; You J; Shi H; Xue X; Huang J; Xu L; Jiang G; Yuan L; Gong X; Luo H; Ge J; Cui Z; Zou Y
    J Mol Cell Cardiol; 2018 May; 118():193-207. PubMed ID: 29626503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA circRNA_000203 aggravates cardiac hypertrophy via suppressing miR-26b-5p and miR-140-3p binding to Gata4.
    Li H; Xu JD; Fang XH; Zhu JN; Yang J; Pan R; Yuan SJ; Zeng N; Yang ZZ; Yang H; Wang XP; Duan JZ; Wang S; Luo JF; Wu SL; Shan ZX
    Cardiovasc Res; 2020 Jun; 116(7):1323-1334. PubMed ID: 31397837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-206 Mediates YAP-Induced Cardiac Hypertrophy and Survival.
    Yang Y; Del Re DP; Nakano N; Sciarretta S; Zhai P; Park J; Sayed D; Shirakabe A; Matsushima S; Park Y; Tian B; Abdellatif M; Sadoshima J
    Circ Res; 2015 Oct; 117(10):891-904. PubMed ID: 26333362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy.
    Li Q; Xie J; Wang B; Li R; Bai J; Ding L; Gu R; Wang L; Xu B
    PLoS One; 2016; 11(2):e0148480. PubMed ID: 26914935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.